RA Capital Nexus Fund II, L.P.
Related Filers (15)
- Kolchinsky Peter (53)
- Shah Rajeev M. (53)
- RA Capital Healthcare Fund LP (53)
- RA CAPITAL MANAGEMENT, L.P. (53)
- Cytek Biosciences, Inc. (9)
- DICE Therapeutics, Inc. (7)
- AN2 Therapeutics, Inc. (7)
- PepGen Inc. (6)
- Acumen Pharmaceuticals, Inc. (5)
- Eliem Therapeutics, Inc. (5)
- RA Capital Nexus Fund, L.P. (5)
- ARS Pharmaceuticals, Inc. (5)
- Icosavax, Inc. (4)
- Acrivon Therapeutics, Inc. (3)
- Janux Therapeutics, Inc. (2)
- Show More ...
Ownership (52)
4
Tuesday, 2/13/2024
PepGen Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/25/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/31/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/22/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/9/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/21/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/28/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
Eliem Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/30/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/27/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/21/2022
Acrivon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/16/2022
Acrivon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/10/2022
ARS Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/10/2022
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/9/2022
Acrivon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/19/2022
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/5/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/28/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/23/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/8/2022
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Eliem Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Thursday, 5/12/2022
PepGen Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/12/2022
PepGen Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/10/2022
PepGen Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/5/2022
PepGen Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 3/31/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/30/2022
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/24/2022
AN2 Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/16/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/11/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/25/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/16/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
DICE Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 8/16/2021
Eliem Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/11/2021
Eliem Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 8/9/2021
Eliem Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/4/2021
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/29/2021
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/28/2021
Icosavax, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 7/22/2021
Cytek BioSciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/8/2021
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/30/2021
Acumen Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities